Island Pharmaceuticals Limited (ILA.AX)
AUD 0.19
(11.76%)
AUD 0.19
(11.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.86 Million AUD | -1.2% |
| 2023 | -2.83 Million AUD | -8.58% |
| 2022 | -2.6 Million AUD | -22.58% |
| 2021 | -2.12 Million AUD | -323115.05% |
| 2020 | -658.00 AUD | 99.85% |
| 2019 | -430 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -2.86 Million AUD | -1.2% |
| 2024 Q4 | -854.62 Thousand AUD | 0.0% |
| 2024 Q2 | -1.15 Million AUD | -100.0% |
| 2024 Q3 | -854.62 Thousand AUD | 26.01% |
| 2024 Q1 | -577.53 Thousand AUD | 52.65% |
| 2023 Q2 | -1.61 Million AUD | -100.0% |
| 2023 Q1 | -805.39 Thousand AUD | 54.26% |
| 2023 FY | -2.83 Million AUD | -8.58% |
| 2023 Q4 | -1.21 Million AUD | -100.0% |
| 2023 Q3 | -609.83 Thousand AUD | 62.14% |
| 2022 Q3 | -880.43 Thousand AUD | -4.07% |
| 2022 Q4 | -1.76 Million AUD | -100.0% |
| 2022 FY | -2.6 Million AUD | -22.58% |
| 2022 Q2 | -846.02 Thousand AUD | -100.0% |
| 2022 Q1 | -423.01 Thousand AUD | 80.11% |
| 2021 Q1 | -41.00 AUD | 0.0% |
| 2021 FY | -2.12 Million AUD | -323115.05% |
| 2021 Q4 | -2.12 Million AUD | -100.0% |
| 2021 Q3 | -1.06 Million AUD | -2593402.44% |
| 2021 Q2 | -41.00 AUD | 0.0% |
| 2020 FY | -658.00 AUD | 99.85% |
| 2019 FY | -430 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 46.772% |
| Acrux Limited | -5.8 Million AUD | 50.615% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 36.397% |
| Biome Australia Limited | -1.67 Million AUD | -71.495% |
| BTC Health Limited | 1.05 Million AUD | 371.425% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 77.14% |
| CSL Limited | 2.64 Billion AUD | 100.108% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 93.232% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 108.038% |
| Noxopharm Limited | -3.57 Million AUD | 19.949% |
| PharmAust Limited | -9.03 Million AUD | 68.288% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 55.078% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 65.231% |
| PYC Therapeutics Limited | -37.72 Million AUD | 92.407% |
| Race Oncology Limited | -13.81 Million AUD | 79.273% |
| Starpharma Holdings Limited | -8.16 Million AUD | 64.92% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 141.127% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 79.348% |
| Memphasys Limited | -4.44 Million AUD | 35.518% |
| Nyrada Inc. | -1.38 Million AUD | -106.627% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -97.37% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 154.967% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -18.892% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 92.167% |
| Patrys Limited | -3.53 Million AUD | 19.068% |
| Dimerix Limited | -17.07 Million AUD | 83.225% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 101.823% |
| Orthocell Limited | -7.18 Million AUD | 60.112% |
| Imugene Limited | -149.68 Million AUD | 98.086% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 70.606% |
| Immutep Limited | -39.89 Million AUD | 92.821% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 67.25% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 85.022% |
| Nanollose Limited | -1.15 Million AUD | -147.66% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -74.461% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 983.476% |
| Biotron Limited | -3.43 Million AUD | 16.651% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 94.026% |
| Tissue Repair Ltd | -4.13 Million AUD | 30.782% |
| AnteoTech Limited | -8.88 Million AUD | 67.746% |
| Hexima Limited | -933.87 Thousand AUD | -206.714% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 95.117% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 83.782% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 16.652% |
| Actinogen Medical Limited | -13.04 Million AUD | 78.042% |
| Immuron Limited | -6.93 Million AUD | 58.709% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 47.727% |